EcoDrugPlus

Cytochrome P450 26a1

Ensembl ID : ENSTRUG00000002005
Gene Symbol: LOC101063989
3 Cross references
194 Possible Orthologues:

Cytochrome P450 3a27-Like

Ensembl ID : ENSTRUG00000001326
Gene Symbol: LOC101076110
4 Cross references
138 Possible Orthologues:

Cytochrome P450 3a30-Like

Ensembl ID : ENSTRUG00000007021
Gene Symbol: LOC101069124
2 Cross references
47 Possible Orthologues:

Cytochrome P450 Family 17 Polypeptide 1

Ensembl ID : ENSTRUG00000001509
Gene Symbol: CYP17A1
3 Cross references
209 Possible Orthologues:

Cytochrome P450, Family 17, Subfamily A, Polypeptide 1

Ensembl ID : ENSTRUG00000028854
Gene Symbol: CYP17A1
1 Cross references
209 Possible Orthologues:

Cytochrome P450, Family 46, Subfamily A, Polypeptide 1, Tandem Duplicate 4

Ensembl ID : ENSTRUG00000022490
Gene Symbol: CYP46A1.4
1 Cross references
258 Possible Orthologues:

Delta-Type Opioid Receptor

Ensembl ID : ENSTRUG00000005296
Gene Symbol: LOC101075730
4 Cross references
214 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSTRUG00000011276
Gene Symbol: LOC101076766
3 Cross references
197 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSTRUG00000013741
Gene Symbol: LOC101068751
3 Cross references
179 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSTRUG00000010376
Gene Symbol: LOC101079075
3 Cross references
191 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSTRUG00000012581
Gene Symbol: DGAT1
4 Cross references
191 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1-Like

Ensembl ID : ENSTRUG00000011659
Gene Symbol: LOC101072465
3 Cross references
190 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).